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1. Introduction
  Diabetes mellitus is a group of metabolic disease 
characterized by hyperglycaemia resulting from defects in 
insulin secretion, insulin action or both[1]. The disease has 
now become an epidemic with a world wide incidence of 
about 5% of the population and now kills more than AIDS[2]. 
The international diabetes, federation has predicted that 
the number of individuals with diabetes will increase from 
240 million in 2007 to 380 million in 2025 with 80% of the 
disease burden in low and middle income countries[3].
  The two main types of diabetes include: the insulin 
dependent diabetes mellitus whose main characteristics is 
deficiency of insulin resulting from loss of insulin producing 
beta cells of the islets of Langerhans in the pancreas and 
the non-insulin dependent diabetes mellitus which is due 
to either insulin resistance or reduced sensitivity coupled 
with relatively reduced insulin secretion which in some 
cases become absolute[4] and this globally is the commonest 
form[5]. 
  The treatment of diabetes currently is based on various 
oral hypoglycaemic drugs along side insulin[6]; however, 
synthetic hypoglycaemic agents are associated with serious 
side effects which include: hematological effects, coma, 
disturbances of the liver and kidney functions and in 
addition they are not suitable for use during pregnancy[7]. 
These side effects lead to the search for alternative remedies 
which may produce similar degree of efficacy with little or 
no adverse effects. Ethnobotanical information indicates 
that more than 800 plants are used as traditional remedies 
for the treatment of diabetes due to their effectiveness, less 
side effects and relatively low cost[8].
  Diaphananthe bidens (D. bidens) (AFZEL. EX SW) SCHLTR 
Objective: To evaluate the methanol leaf extract of Diaphanathe bidens (D. bidens) (AFZEL. EX 
SW) SCHLTR for antihyperglycemic activity in order to confirm it antidiabetic potential. Methods: 
D. bidens was extracted by cold maceration for 48 h and concentrated in vacuo to yield D. bidens 
extract (DBE). Hyperglycemia was induced by intraperitoneal administration of streptozotocin
(75 mg/kg). Oral glucose tolerance test was done with 2 g/kg glucose load in normal rats. DBE 
(150, 300 and 600 mg/kg) was administered orally, while tolbutamide (100 mg/kg, p.o.) was used 
as the standard reference drug. Blood glucose levels determined using ACCUCHEK glucose auto-
analyzer. The acute toxicity and phytochemical studies were also carried out. Results: DBE
(600 mg/kg) and tolbutamide (100 mg/kg) significantly (P<0.05, 0.005) reduced blood glucose 
levels of rats between 120 and 480 min post administration in normal rats. In the streptozotocin- 
induced hyperglycemic rats, DBE  (150, 300, 600 mg/kg) caused significant (P<0.001)dose- and 
time- dependent reduction in the blood glucose levels by 1.7%, 22.8% and 43.4%, respectively at 
480 min compared to the negative control group. DBE (600 mg/kg) reduced the blood glucose level 
of rats by 1.2% in the oral glucose tolerance test when compared with the normal saline treated 
group. The acute toxicity test showed that DBE was safe at the doses used and the phytochemical 
screening revealed the presence of saponins, steroids, tannins and terpernoids. Conclusions: D. 
bidens extract possess antihyperglycemic activity which may be mediated through pancreatic and 
extra-pancreatic pathways, thereby justifying it folkloric use.
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is an epiphyte and belongs to the family Orchidaceae with 
tough wiry stems. It attains several metres in length which 
makes the plant become gracefully pendulous from the 
branches of foot-hill forest trees, free flowing with salmon 
pink, yellowish pink or white flowers[9]. The common names 
include wax orchid (English), “Ikori” (Yoruba Tribe in 
Nigeria) and “Bombins” (Sierra Leone)[9,10]. Little is known 
about the medicinal properties of this plant; however, the 
natives in South Eastern Nigeria use the leaf decoction as a 
remedy for diabetes mellitus, inflammatory conditions and 
for management of asthmatic conditions. 
  Based on these traditional uses, this present study was 
undertaken to investigate the antihyperglycaemic activities 
of the methanol leaf extract of D. bidens with the aim of 
establishing its efficacy and the pharmacological basis for 
its folkloric use. 
2. Materials and methods 
2.1. Plant collection and identification 
  The fresh leaves were collected from Ede Oballa in Nsukka 
Local Government Area, Enugu State, Nigeria and were 
identified by a Taxonomist, Mr. AO Ozioko of Bioresources 
development and conservation programme (BDCP) Aku 
Road, Nsukka and a voucher specimen (BDCP/H.8910) 
deposited in the University of Nigeria Nsukka herbarium for 
reference. 
2.2. Extraction of plant material
  Cold maceration extraction method was used for the 
extraction of the plant materials. The fresh leaves of the 
plant were cut into tiny pieces, dried under mild sunlight 
and pulverized into a coarse powder of about 1 mm in 
diameter. Two hundred grammes (200 g) of the pulverized 
material were macerated in 750 mL of 80% aqueous 
methanol for 48 hours with intermittent shaking at 2 hours 
interval. The extract was filtered using Whitman filter 
papers (No.1) and later concentrated in vacuo using rotary 
evaporator at 40℃ and 210 milibar and a freeze dryer. 
The yield was calculated and the crude extract labeled as 
D. bidens extract (DBE) was stored in a refrigerator at the 
temperature of 10℃ until time of use.
2.3. Experimental animals
  Adult male Wistar albino mice (22-31 g) and rats (150-180 
g) of either sex from the Laboratory Animal Unit of Faculty 
of Veterinary Medicine, University of Nigeria, Nsukka were 
used for the experiments. The animals were kept in stainless 
steel cages and clean drinking water provided ad libitum 
while they were fed with standard commercial pelleted feed 
(Vital Feed® Nigeria). The temperatures varied between 27-
30℃ and relative humidity of about 55%-60% with 12-h 
light-dark cycle and adequate ventilation maintained in the 
animal house. Ethical conditions governing the conducts 
of experiments with life animals as stipulated by Ward and 
Elsea[11] were strictly observed. Also, the experimental 
protocol was approved by the institution’s ethical committee.
2.4. Acute toxicity test
  The method of Lorke[12] was employed in this study. 
Briefly, 25 mice of both sexes were randomly grouped into 5e 
groups (A-E) of five mice per group and were dosed with 100, 
200, 500 and 1 000 and 2 000 mg/kg of DBE orally by gastric 
gavage. The animals were given feed and water ad libitum 
and were observed over a period of 48 h for signs of toxicity 
and mortality.
2.5. Effect of DBE on blood glucose levels of normoglycaemic 
rats
  Twenty five (25) adolescent albino rats of either sex were 
grouped into 5 of 5 rats per group after 18 h fast and treated as 
follows: Group 1 (negative control group) received 10 mL/kg
of normal saline, group 2 (positive control) received 
tolbutamide (100 mg/kg) while groups 3, 4 and 5 received 
150, 300 and 600 mg/kg of DBE, respectively. Blood samples 
were collected from each of the rats through tail snip at 0 
min, 30, 60, 120, 240, 360 and 480 min. The blood glucose 
levels was measured using auto analyzer (AccuCheck 
Advantage II®) glucose kit[13]. 
2.6. Effect of DBE on streptozotocin-induced hyperglycaemic 
Rats
2.6.1. Induction of hyperglycemia
  The modified method of Dash et al[13] was used for this 
study. The rats were weighed and fasted for 18 h and 
allowed free access to clean drinking water ad libitum. 
Hyperglycaemia was induced by intraperitoneal injection 
of 75 mg/kg streptozotocin (STZ) in citrate buffer (pH 4.5). 
Hyperglycaemia was confirmed  in the STZ-treated rats 48 h
later by measuring fasting blood glucose levels (18 h fast) 
using auto analyzer (AccuCheck Advantage II®)) glucose 
kit with blood collected from the tail vein. Rats with fasting 
blood glucose levels above 350 mg/dL were considered 
hyperglycaemic and included in the study. 
2.6.2. Experimental design
  Hyperglycaemic rats were randomly divided into 5 groups 
of 5 rats each.  The fasting blood glucose levels of the rats 
in each group were determined using the same method as 
above representing the fasting blood glucose level at 0 min 
and then treated as follows[13]:
Group 1 (negative control) rats received 10 mL/kg normal 
saline;Group 2 (positive control) rats received 100 mg/kg 
tolbutamide; Group 3, 4 and 5 (test groups) rats were given 
150, 300 and 600 mg/kg of DBE, respectively, all by gastric 
gavage. The blood glucose levels of the rats were tested at 
0, 60, 120, 180, 360 and 480 min after administration of drug 
and DBE using auto analyzer described as above. 
2.7. Effect of DBE on oral glucose tolerance test in 
normoglycaemic rats  
  This study was done using the modified method of Aslan et al[14].
Anaga Aruh Ottah et al./Asian Pacific Journal of Tropical Medicine (2012)192-196194
  Briefly, ten (10) albino Wister rats were divided into 2 
groups of 5 rats each and fasted for 18 h. Group 1 rats were 
given normal saline 10 mLl/kg, while group 2 rats were 
treated with 600 mg/kg of DBE by gastric gavage. The blood 
glucose level of each of the rats was measured immediately 
after treatment, 30 minutes later the rats were given glucose 
load at the dose of 2 g/kg per os.  Blood samples were then 
collected by tail snip from the rats at 0 min (immediately 
after glucose load), 30, 60, 120 and 180 min and the blood 
glucose levels measured using auto analyzer as above. 
2.8. Phytochemical spot tests of DBE
  The phytochemical spot tests were done using the method 
of Harbourne and Trease and Evans[15,16].    
2.9. Data analysis 
  The results were presented as mean 依 SEM and were 
analyzed using one-way analysis of variance (ANOVA). 
The differences between the means were separated by LSD 
PostHoc analysis and values of P<0.05 were considered 
statistically significant.
3. Results 
3.1. Plant extraction 
  The methanolic leaf extract of D. bidens was greenish black 
in colour which was odourless and the yield was 1.63% w/w 
dry matter.
3.2. Acute toxicity test
  The animal clustered together following the administration 
of D. bidens and 2 deaths were recorded at the dose of 2 000 
mg/kg at the 10th h after DBE administration. 
3.3. Effect of D. bidens on normoglycaemic rats
  The effect of  the DBE on the glucose levels of 
normoglycaemic rats is presented in Table 1. The result 
showed that there was an increase in blood glucose level 
by 44.4% at the 8th hour in the normal saline treated group 
(negative control). Tolbutamide and DBE at the dose of 
600 mg/kg caused a time dependent and various levels of 
significant (P< 0.05-0.005) reduction of blood glucose levels 
of the rats.
  The blood glucose levels of the rats were reduced DBE
(600 mg/kg) from (89.70依6.50) mg/dL to (47.43依1.70) mg/dL
at the 8th hour representing 47.1% reduction while the 
reference drug tolbutamide caused a reduction of the blood 
glucose levels from (109.36依4.60) mg/dL at 0 min to (43.15
依7.60) mg/dL at the 240 min representing 60.5% reduction 
but there was a rise to (95.16依9.20) mg/dL at the 8th hour 
representing 13.0% reduction.
  At the doses of 150 and 300 mg/kg of the extract, the blood 
glucose levels of the rats were increased by 14.6% and 
12.8%, respectively.
3.4. Induction of hyperglycemia
  After 48 h of intraperitoneal injection of 75 mg/kg
streptozotocin, the rats showed clinical signs of 
polyuria, polydipsia, weight loss (data not included) and 
hyperglycemia which were typical of diabetes mellitus. 
3.5. Effect of DBE on STZ- induced hyperglycaemic rats 
  The result of the effect of DBE on mean blood glucose level 
in STZ-induced hyperglycaemia is presented in Figure 1. 
The result showed that the blood glucose levels of group 1 
(negative control) were increased from 445.04418.54 at zero 
min to 485.85依23.55 at the 480th min representing 8.4% 
increase. Generally, DBE caused a significant (P<0.001) 
dose and time dependent reduction in the blood glucose 
levels of the rats 150, 300 and 600 mg/kg, reducing the mean 
blood glucose levels by 1.7%, 22.8% and 43.4%, respectively 
at the 480th min when compared to the negative group. The 
reference drug tolbutamide (100 mg/kg) stabilized the blood 
glucose level throughout the period of the study (Figure 1).
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Figure 1. Effect of DBE on blood glucose level in STZ induced 
hyperglycaemic rats.
*: P<0.05 compared with 0 min.
  Also the extract at the doses of 300 and 600 mg/kg caused 
various levels of reduction (P<0.01–P<0.001) of the mean 
blood glucose levels from 240-480 min, while at the dose 
of 150 mg/kg DBE though there was reduction in the 
blood glucose levels of the rats, it was not statistically 
significant (P >0.05) and that was observed in 360 min after 
administration of DBE. 
3.6. Effect of DBE on oral glucose tolerance test  in 
normoglycaemic Rats
  Figure 2 shows the result of the effect of DBE on oral 
Anaga Aruh Ottah et al./Asian Pacific Journal of Tropical Medicine (2012)192-196 195
glucose tolerance test in normal rats. After 30 min of glucose 
load, there was about a two folds increase in the mean 
blood glucose levels of the rats in the two groups. This was 
followed by a gradual decrease resulting in 30.4% and 29.2% 
reduction by the extract (600 mg/kg) and normal saline, 
respectively at the 180 min after administration.
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Figure 2. Effect of DBE on oral glucose tolerance test  in normal rats.
3.7. Phytochemical screening
  The phytochemical spot tests showed that the methanol 
leaf extract of D. bidens contains saponins, tannins, steroids 
and terpenoids.
4. Discussion 
  The present study was designed to investigate the 
antihyperglycaemic effects of the methanol leaf extract of 
D. bidens using normal and STZ-induced hyperglycaemic 
models in rats. The methanol leaf extract of D. bidens was 
greenish black in colour and gave a yield of 1.63% w/w 
dry matter. Acute toxicity test of the DBE in mice showed 
that there were signs of depression and clustering together 
which suggests the involvement of central nervous system. 
Mortality (40%) was recorded in 10 h after administration of 
the extract in the mice that received 2 000 mg/kg DBE. Based 
on this, the doses of DBE used in this study did not exceed 
600 mg/kg.
  STZ is a broad spectrum antibiotics glucosamine nitrosourea 
compound extracted from Streptomyces acromogens. STZ-
induced hyperglycaemia is associated with the generation 
of reactive oxygen species causing oxidative damage[17] 
and causes the destruction of 毬-cells, resulting in the 
development an insulin dependent syndrome characterized 
by severe hyperglycaemia, polydipsia, insulinopenia and 
weight loss[18]; which is characteristic of type 2 diabetes 
mellitus or non-insulin dependent diabetes mellitus.
  The results of this study demonstrated that tolbutamide 
(100 mg/kg) and DBE significantly (P<0.05, 0.005) reduced 
blood glucose level in normal rats when compared with 
the negative control. This effect commenced 30 min after 
drug administration and lasted till 4 h, while that of DBE 
started 1 h after extract administration and lasted throughout 
the duration of the study. Since DBE (600 mg/kg) caused 
47% reduction in blood glucose level in normal rats, 
therefore individuals who use this plants for other folkloric 
reasons other than diabetes mellitus may stand the risk of 
hypoglycaemic coma.
  Based on the finding above, STZ-induced diabetic model 
in rats was used to evaluate the antihyperglycaemic effect 
of DBE in rats. The therapeutic objectives are to normalize 
glucose-induced insulin secretion and restore glucose 
transport into insulin sensitive tissues[19]. DBE may be 
one of such plants that may restore insulin sensitivity in 
non-insulin dependent diabetes mellitus. Our findings 
showed that the hyperglycaemia was very severe (above 
700 mg/dL) and DBE (600 mg/kg) able to reduced blood 
glucose level from 755.59 mg/dL at zero time to 427.78 mg/
dL 8 h (about 57% reduction) after DBE administration. 
Also botanical products can improve glucose metabolism 
and the overall condition of individuals with diabetes not 
only by hypoglycaemic effects but also by improving lipid 
metabolism, antioxidant status and capillary function[20]. 
D. bidens leaf extract may have achieved its blood glucose 
lowering effects through one or a combination of the above 
mechanisms. 
  To confirm antihyperglycaemic effect of DBE, oral glucose 
tolerance test was conducted normal rats. Single dose 
of 600 mg/kg DBE used because it produced the highest 
antihyperglycaemic effect in STZ-induced hyperglycaemic 
study. DBE (600 mg/kg) significantly (P<0.05) decreased 
the blood glucose level between 2 and 3 h after glucose 
load. This shows that DBE-induced antihypergylcaemic 
property may involve pancreatic and extra-pancreatic 
mechanisms. Pancreatic involvement may be due to release 
of insulin from healthy pancreas in normal rats[21], while 
extra pancreatic pathway may be as a result of increased 
glucose utilization by the tissues and or reduced intestinal 
absorption of glucose[22-28]. 
  The phytochemical screening showed that the methanol 
leaf extract of D. bidens contains sapponins, tannins, steroids 
and terpernoids. Tannins and flavonoids isolated from other 
antidiabetic plants have been found to stimulate secretion or 
possess insulin- like effects[29]. It is therefore possible that 
Table 1
 Effect of DBE on the mean blood glucose levels of normoglycemic rats(mg/dL).
Group Treatment
Fasting  blood glucose level
0 min 30 min 1 h 2 h 4 h 6 h 8 h
1 Normal saline(10 mL/kg)   48.11依6.40 56.52依5.30 63.62依7.90   68.11依6.30   64.25依14.90   80.19依16.80 86.70依15.80
2 Tolbutamide (100 mg/kg) 109.36依4.60 57.42依6.10* 56.42依12.60**   52.90依12.50**   43.15依7.60**   71.78依7.00 95.16依9.20
3 DB   extract (150 mg/kg)   82.90依6.70 84.00依4.60 86.80依8.00   88.40依4.30   86.80依4.30 101.60依5.20 96.00依8.12
4 DB extract (300 mg/kg)   78.91依1.60 96.53依15.30 87.64依6.40 113.45依21.60 126.18依42.30   83.64依7.70 90.46依11.70
5 DB extract (600 mg/kg)   89.70依6.50 77.71依3.20 71.12依3.20*   73.43依3.30*   57.43依7.00**   53.71依6.40** 47.43依1.70**
     *P < 0.05; ** P < 0.005 when compared to negative control group. 
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the antihyperglycaemic activity of D. bidens leaf extract may 
be due to its phytoconstituents.
  In conclusion, the use of DBE in folkloric medicine, thus, 
has a high scientific correlation with the data generated 
in this study, where DBE administered orally produced 
a significant decrease in the blood glucose levels in 
normoglycaemic and STZ induced-diabetic rat models and 
therefore suggests its antidiabetic potential and may have 
acted through other mechanism(s) other than direct effect 
on glucose uptake. However, more work should be carried 
out to determine the toxicity profile, isolate the bioactive 
compound(s) in the plant and to determine the exact 
mechanism(s) of action. 
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